Yoseph Shaaltiel
2009
In 2009, Yoseph Shaaltiel earned a total compensation of $619.6K as Executive Vice President, Research and Development at Protalix BioTherapeutics, a 39% increase compared to previous year.
Compensation breakdown
| Bonus | $160,000 |
|---|---|
| Option Awards | $225,336 |
| Salary | $196,271 |
| Other | $37,981 |
| Total | $619,588 |
Shaaltiel received $225.3K in option awards, accounting for 36% of the total pay in 2009.
Shaaltiel also received $160K in bonus, $196.3K in salary and $38K in other compensation.
Rankings
In 2009, Yoseph Shaaltiel's compensation ranked 6,123rd out of 9,885 executives tracked by ExecPay. In other words, Shaaltiel earned more than 38.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,123 out of 9,885 | 38th |
Division Manufacturing | 2,220 out of 3,690 | 40th |
Major group Chemicals And Allied Products | 479 out of 866 | 45th |
Industry group Drugs | 319 out of 638 | 50th |
Industry Biological Products, Except Diagnostic Substances | 60 out of 133 | 55th |
Source: SEC filing on May 21, 2012.
Shaaltiel's colleagues
We found three more compensation records of executives who worked with Yoseph Shaaltiel at Protalix BioTherapeutics in 2009.